Cassandra Adams is a translational scientist in the Centre for Medicines Discovery. She received her D.Phil. in Clinical Laboratory Sciences at the University of Oxford in 2010 under the supervision of Prof. Nick La Thangue. She then undertook post-doctoral research on radiation-induced tumorigenesis in the laboratory of Prof. Allan Balmain at the University of California, San Francisco (UCSF). During which time she was awarded a full fellowship from the Leukemia and Lymphoma Society. Subsequently she became a senior staff scientist in Genome Analysis Core Facility, UCSF where she launched and managed the new Single Cell Analysis Center.
Cassandra joined the BRC team in 2018 as a translational scientist and is currently working on a range of projects accelerating novel drug targets downstream in a variety of therapeutic areas; including rare disease, oncology and inflammatory disease.